Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US

Author:

Bhattacharya Kaustuv12,Bentley John P.12,Ramachandran Sujith12,Chang Yunhee3,Banahan Benjamin F.12,Shah Ruchit4,Bhakta Nickhill5,Yang Yi12

Affiliation:

1. Center for Pharmaceutical Marketing and Management, University of Mississippi School of Pharmacy, University

2. Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University

3. Department of Nutrition and Hospitality Management, University of Mississippi, University

4. Pharmerit International, Bethesda, Maryland

5. Department of Global Pediatric Medicine, St Jude Children’s Research Hospital, Memphis, Tennessee

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference42 articles.

1. Estimating the costs of therapy in patients with relapsed and/or refractory multiple myeloma: a model framework.;Roy;Am Health Drug Benefits,2015

2. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.;Chen;Med Oncol,2017

3. Economic and clinical impact of multiple myeloma to managed care.;Cook;J Manag Care Pharm,2008

4. Trends in overall survival and costs of multiple myeloma, 2000-2014.;Fonseca;Leukemia,2017

5. Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.;Petrucci;Tumori,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3